| Literature DB >> 20184723 |
Nejla Güngör1, Jeroen L A Pennings, Ad M Knaapen, Roland K Chiu, Marco Peluso, Roger W L Godschalk, Frederik J Van Schooten.
Abstract
BACKGROUND: Lung cancer often develops in association with chronic pulmonary inflammatory diseases with an influx of neutrophils. More detailed information on inflammatory pathways and the role of neutrophils herein is a prerequisite for understanding the mechanism of inflammation associated cancer.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20184723 PMCID: PMC2838834 DOI: 10.1186/1465-9921-11-24
Source DB: PubMed Journal: Respir Res ISSN: 1465-9921
Figure 1Venn diagram showing the distribution of the 1.5-fold differentially expressed genes over the three groups: LPS exposed mice compared to sham mice (LPS + PMN), LPS exposed neutrophil depleted mice compared to sham mice (LPS -PMN) and LPS exposed mice compared to LPS exposed neutrophil depleted mice (+ PMN vs. - PMN).
Pathways significantly modulated by LPS induced lung inflammation as found in MetaCore
| Main cellular process | Modulated pathways | Genes in pathway | ||||
|---|---|---|---|---|---|---|
| Expressed | total | |||||
| + PMN | - PMN | + PMN | - PMN | |||
| Cell cycle | Role of APC in cell cycle regulation | 1,040E-09 | 8,149E-08 | 15 | 12 | 32 |
| Chromosome condensation in prometaphase | 4,131E-06 | 8,392E-11 | 9 | 12 | 20 | |
| The metaphase checkpoint | 4,423E-06 | 1,474E-04 | 12 | 9 | 36 | |
| Spindle assembly and chromosome separation | 3,170E-04 | 1,937E-03 | 9 | 7 | 32 | |
| Start of DNA replication in early S phase | 1,284E-03 | 3,115E-02 | 8 | 5 | 31 | |
| Initiation of mitosis | 1,544E-03 | 2,483E-03 | 7 | 6 | 25 | |
| Sister chromatid cohesion | 1,530E-02 | 5 | 21 | |||
| Transition and termination of DNA replication | 1,523E-02 | 5 | 26 | |||
| Role of Nek in cell cycle regulation | 2,390E-02 | 5 | 29 | |||
| Nucleocytoplasmic transport of CDK/Cyclins | 4,386E-02 | 3 | 14 | |||
| Immune response | Alternative complement pathway | 4,539E-07 | 2,737E-02 | 12 | 5 | 30 |
| Fc gamma R-mediated phagocytosis | 1,606E-03 | 9,058E-03 | 8 | 6 | 32 | |
| Antigen presentation by MHC class II | 6,046E-03 | 2,644E-03 | 4 | 4 | 11 | |
| Classic complement pathway | 1,517E-05 | 12 | 40 | |||
| Antiviral actions of Interferons | 2,431E-04 | 9 | 31 | |||
| CCR3 signalling | 8,728E-04 | 12 | 59 | |||
| Lectin Induced complement pathway | 1,251E-03 | 9 | 38 | |||
| Lipoxin inhibitory action on Superoxide production | 1,544E-03 | 2,483E-03 | 7 | 6 | 25 | |
| IFN alpha/beta signalling pathway | 6,214E-03 | 6 | 24 | |||
| IL-10 signalling pathway | 2,245E-02 | 5 | 23 | |||
| Antigen presentation by MHC class I | 3,675E-02 | 5 | 26 | |||
| Transcription regulation of granulocyte development | 3,115E-02 | 5 | 31 | |||
| Oxidative stress | ROS production | 8,932E-04 | 4,113E-02 | 7 | 4 | 23 |
| Apoptosis | Inhibition of ROS induced apoptosis | 3,675E-02 | 5 | 26 | ||
| G protein signalling | Rac2 regulation pathway | 4,957E-03 | 4,113E-02 | 6 | 4 | 23 |
| RAC1 in cellular process | 1,361E-02 | 6 | 28 | |||
| Cytoskeleton remodelling | Regulation of actin cytoskeleton by Rho GTPases | 8,972E-03 | 5 | 23 | ||
| Alpha-1A adrenergic receptor-dependent inhibition of PI3K | 2,887E-02 | 3 | 12 | |||
| Metabolic process | Lipoprotein metabolism I. Chylomicron, VLDL and LDL metabolism | 1,630E-02 | 9,007E-07 | 3 | 6 | 8 |
| Lipoprotein metabolism II. HDL metabolism | 1,630E-02 | 9,007E-07 | 3 | 6 | 8 | |
| G-alpha(q) regulation of lipid metabolism | 2,245E-02 | 5 | 23 | |||
| Urea cycle | 3,675E-02 | 5 | 26 | |||
| LDL metabolism during development of fatty streak lesion | 1,870E-02 | 2 | 4 | |||
Note: Significantly modulated 1.5-fold changed genes (P value < 0.05) versus total number of genes in pathway
Pathways significantly modulated by neutrophil depletion during LPS induced lung inflammation as found in MetaCore
| Main cellular process | Modulated pathways | Genes in pathway | ||
|---|---|---|---|---|
| expressed | total | |||
| Cell cycle | Role of APC in cell cycle regulation | 1,012E-02 | 4 | 32 |
| Spindle assembly and chromosome separation | 1,012E-02 | 4 | 32 | |
| Immune response | IFN alpha/beta signalling pathway | 2,740E-05 | 6 | 24 |
| Alternative complement pathway | 8,024E-03 | 4 | 30 | |
| Oncostatin M signaling via MAPK | 1,683E-02 | 4 | 35 | |
| NKG2D signalling | 4,297E-02 | 3 | 29 | |
| IL-3 activation and signallng pathway | 4,685E-02 | 3 | 30 | |
| Response to extracellular stimulus | Angiotensin signalling via STATs | 2,917E-02 | 3 | 25 |
| Ligand dependent activation of the ESR-1/AP-1 pathway | 4,756E-02 | 2 | 13 | |
| Other | Mucin expression in CF via IL-6, IL-17 signalling pathways | 3,926E-02 | 3 | 28 |
Note: Significantly modulated 1.5-fold changed genes (P value < 0.05) versus total number of genes in pathway